Further studies using (semi-)automated delineations of (3D-)ROIs and including non-radiologic complete responders on DCE-MRI should be conducted to further assess the role of DWI in response evaluation after NST in HER2-positive breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.